|
Volumn 28, Issue 8, 2002, Pages 678-685
|
Fluridil, a rationally designed topical agent for androgenetic alopecia: First clinical experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 PROPANOL;
4 [3 (4 HYDROXYBUTYL) 4,4 DIMETHYL 2,5 DIOXO 1 IMIDAZOLIDINYL] 2 TRIFLUOROMETHYLBENZONITRILE;
ANDROSTANOLONE;
ANTIANDROGEN;
BP 34;
DRUG METABOLITE;
FLURIDIL;
FLUTAMIDE;
MINOXIDIL;
NILUTAMIDE;
PETROLATUM;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ADULT;
ANIMAL EXPERIMENT;
ARTICLE;
BLOOD CHEMISTRY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DESIGN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
HAIR GROWTH;
HEMATOLOGY;
HUMAN;
HUMAN CELL;
LIBIDO;
MALE;
MALE TYPE ALOPECIA;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SENSITIZATION;
SEXUAL FUNCTION;
SKIN IRRITATION;
TESTOSTERONE BLOOD LEVEL;
ADMINISTRATION, TOPICAL;
ADULT;
ALOPECIA;
AMIDES;
ANDROGEN ANTAGONISTS;
DOUBLE-BLIND METHOD;
HUMANS;
HYDROCARBONS, FLUORINATED;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 0036677252
PISSN: 10760512
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1524-4725.2002.02017.x Document Type: Article |
Times cited : (38)
|
References (24)
|